LATEST ALERTS
CBD-Intel podcast editor Jon Bruford meets Dr K CBD’s Dr Ruchira Karunadasa who explains why he believes the company has an important role to play in helping the industry towards mature dialogue, and the impact that
The newly elected German governing coalition has followed through on pre-election promises and included a plan for cannabis legalisation in its coalition agreement – but many questions remain to be answered
A German hemp producer and retailer is going to court hoping to overturn a rejection of its application to import hemp products from Austria. The new German government may pre-empt matters if it makes cannabis sales legal
This week’s regulatory news in brief includes updates from France, Germany, Malta, Slovenia, Ukraine, the US, Argentina, Brazil, Colombia, Israel, Malaysia, Sri Lanka and Uruguay
Switzerland inched closer towards legalising recreational and medical cannabis as a committee of the upper parliamentary chamber backed a proposal to regulate the market
The Russian Ministry of Industry and Trade is planning to clarify the definitions of definition of industrial hemp and the varieties that can be cultivated for industrial purposes by March/April 2022
This week’s regulatory news in brief includes updates from Georgia, Canada, Mexico, the US, Chile, Colombia, India, Japan, Malaysia, Russia and Thailand
This week’s regulatory news in brief includes updates from Portugal, the UK, US, Brazil and Chile
This week’s regulatory news in brief includes updates from France, Finland, Germany, Italy, Lithuania, Switzerland, Ukraine, Canada, the US, Argentina, Brazil, Chile, China, Costa Rica, India New Zealand, Peru and Thailand
Italian campaigners believe they have done enough to secure a referendum on the legalisation of cannabis cultivation for personal use and the decriminalisation of possession
This week’s regulatory news in brief includes updates from the EU, Luxembourg, Portugal, Spain, Switzerland, UK, Canada, Mexico, US, Brazil, Costa Rica, Moldova, Russia
The French ban on CBD flowers looks set to go ahead, with a decree expected to be officially published at the start of November – and an immediate legal appeal against it likely
This week’s regulatory news in brief includes updates from Germany, Ireland, the US, Chile, Malaysia, Nepal, New Zealand, Panama and Pakistan
This week’s regulatory news in brief includes updates from Spain, US, Mexico, Argentina, Chile, Malaysia and New Zealand
Panama is set to become the first country in Central America to legalise and regulate medicinal cannabis after the 44-member National Assembly voted unanimously in favour of doing so
Chile has maintained a rather restrictive approach towards hemp and CBD. It has only recently allowed medicinal use of cannabis-based products, but there are still many legal grey areas as a consequence of the lack of regulation
This week’s regulatory news in brief includes updates from Czech Republic, Germany, Ireland, Spain, Portugal, the US, Ecuador, Malaysia and Thailand
This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products
This week’s regulatory news in brief includes updates from Germany, Hungary, Italy, Lithuania, Spain, the US, Colombia and Uruguay
The USPTO Appeals Board verdict upholding the USPTO’s decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise
Kentucky and Tennessee are among a large number of Southeastern US states that have not yet passed legislation for medical cannabis programs. Here, CBD-Intel examines the issues behind the official reluctance
This week’s regulatory news in brief includes updates from Czech Republic, EU, Finland, Ireland, Italy, Portugal, Spain, UK, US and Costa Rica
What is delta-8 THC and how does US law deal with it, at both federal and state level? In this presentation, CBD-Intel legal analyst Anthony Traurig shares his insights
This week’s regulatory news in brief includes updates from Belgium, Ireland, Italy, UK, US, China, Namibia, Nigeria and Zimbabwe
This week’s regulatory news in brief includes updates from Italy, Germany, Portugal, Spain, Mexico, the US, Belize, China, Colombia, Japan, Malaysia, Panama, South Africa, Thailand and Uruguay
There are now only 14 US states that have yet to implement a medical cannabis programme. Why they are behind the curve on the issue is something of a mystery
Crops of a hemp variety found by Polish authorities to be over the THC limit should never have been tested and regulators are refusing to say why they were, the creator of the variety alleges
There are always people claiming that new changes mean some such country will be “The next big X in cannabis or hemp”. Recent examples include North Macedonia, Thailand, Brazil, Paraguay, Lesotho, Malawi, and of course, Colombia
This week’s regulatory news in brief includes updates from Bosnia and Herzegovina, Croatia, Germany, Spain, Switzerland, the US, Costa Rica, Morocco and Panama
“Today, Colombia eliminates the prohibition of dried flower exports,” president Iván Duque said. “This means that Colombia will enter and participate in the international market in a big way.”
This report covers, state by state, the question of whether each US state allows the sale of hemp-derived CBD vaping products and on what legal terms
A bill to legalise the cultivation and processing of hemp and medical cannabis in Brazil has been dealt a blow with a call for it to be debated and voted on by the country’s full Chamber of Deputies before it is put to the Senate
Uruguay is expected to become one of the first countries to officially legalise the use of CBD in ingestible products
This week’s regulatory news in brief includes updates from the EU, Germany, the US, Fiji and Japan
This report covers the current legal regime for hemp, CBD and cannabis in Portugal
This week’s regulatory news in brief includes updates from Netherlands, Spain, Poland, the US and Guyana
A court case could force the Canadian government to process requests to use psilocybin for psychotherapeutic treatment more quickly
A new study has shown some limited effectiveness for the use of CBD in combatting nicotine withdrawal symptoms
Members of Spain’s ruling party are warming to the idea of legalising medicinal cannabis just months after claiming scientific evidence was insufficient to support such an initiative
A series of changes in Thai law governing both medical cannabis and hemp has made the country one of the most cannabinoid-friendly countries in Asia
This week’s regulatory news in brief includes updates from Spain, the UK, the US, Australia, Colombia, Costa Rica, Ecuador and Israel
There remains no certainty over the future regulation of ingestible CBD products in many jurisdictions
Three US states where recreational cannabis states is legal have now moved to regulate hemp-derived delta-8 THC products by placing them under their state cannabis programmes
This week’s regulatory news in brief includes updates from Czech Republic, Germany, Spain, the US and Colombia
This week’s regulatory news in brief includes updates from Belgium, Ireland, Italy, the US and South Korea
Lina Khan’s appointment to chair the US Federal Trade Commission (FTC) – confirmed last month – was a bit of a surprise
Malawi is set to have its first hemp harvest this year following the licensing of 36 companies. However, despite hopes the plant could change the country’s economic fortunes, it will continue to be strictly regulated
This week’s regulatory news in brief includes updates from the Germany, North Macedonia, Spain, Ukraine, Canada, US, Argentina, Brazil, Israel and Peru
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented?
Three more states have been added to the growing list of US jurisdictions allowing adult use of recreational cannabis. And they have learned lessons on how to frame regulation from those that came before
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
